Hyperthermic carbon dioxide pneumoperitoneum reinforces the inhibition of 5-FU on the proliferation and invasion of colon cancer
Affiliations: Department of General Surgery, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai 200240, P.R. China, Life Science Research Institute, Chinese Academy of Sciences, Shanghai 200031, P.R. China
- Published online on: November 8, 2016 https://doi.org/10.3892/or.2016.5229
- Pages: 492-500
This article is mentioned in:
Laparoscopy has been widely used in colorectal surgery, and CO2 is commonly used to create laparoscopic pneumoperitoneum. However, controversies exist regarding the effect of CO2 pneumoperitoneum on tumor proliferation and metastasis. It is believed that CO2 pneumoperitoneum could potentially promote colon cancer cell proliferation or metastasis under certain conditions (1–3). However, the intraperitoneal hyperthermic chemoperfusion (IHCP) was demonstrated to eradicate free tumor cells and micrometastases, preventing the peritoneal dissemination of tumors, and is commonly used as adjuvant therapy for open surgeries of gastric, colon and ovarian cancers (4). However, the questions that remain open are how to reduce the adverse influence of CO2 pneumoperitoneum on the therapeutic effect of colon cancer surgery, and how to utilize IHCP as the combined therapy. It was speculated that the therapeutic effect may be improved by combined therapy of hyperthermic CO2 pneumoperitoneum and intraperitoneal 5-fluorouracil (5-FU) chemotherapy. In the present study, we investigated the combined effect of hyperthermic CO2 pneumoperitoneum and 5-FU on the proliferation and invasion of colon cancer in vitro and in vivo.
Materials and methods
Cell culture and nude mice
Colon cancer cell line SW-480 was procured from Shanghai Cell Bank of Chinese Academy of Sciences (Shanghai, China) and cultured with L-15 medium containing 10% calf serum in an incubator at 37°C supplemented with 5% CO2, 20% O2 and 75% N2. The culture medium was changed every other day, and the cells at logarithmic growth phase were used for experiments. Nude mice were Balb/C, male, age, 4–6 weeks; weight, 18–20 g, total 72, purchased from East China Normal University Minhang Laboratory Animal Center, raised under the condition of SPF.
Equipment and machine
L-15 culture medium was obtained from Gibco (Thermo Fisher Scientific, Waltham, MA, USA), calf serum was from Hangzhou Tianhang Biological Technology Co., Ltd. (Hangzhou, China) and 5-FU was from Shanghai Xudong Haipu Pharmaceutical Co., Ltd. (Shanghai, China). The following reagents or kits were used: cell counting kit-8 (CCK-8) cytotoxicity analysis kit, Annexin V-FITC apoptosis detection kit (both from Dojindo Laboratories, Kumamoto, Japan), KGI cell DNA content detection kit and Transwell detection kit (Corning, Inc., Corning, NY, USA), TRIzol reagent (Invitrogen, Carlsbad, CA, USA), RNA extraction kit-RNAiso Plus (Takara, Shiga, Japan), First Strand cDNA synthesis kit (Thermo Fisher Scientific), and Maxima SYBR-Green/ROX qPCR master mix (Thermo Fisher Scientific). The first antibodies were procured from Abcam (Cambridge, MA, USA), including mouse monoclonal antibody against heat shock protein-70 (HSP-70) or hypoxia-inducible factor-1α (HIF-1α), and rabbit monoclonal antibody against mitochondrial membrane potential-9 (MMP-9) or caspase-3. Polymerase chain reaction (PCR) primers were designed and synthesized by Sangon Biotech (Shanghai, China). The equipment included the enzyme-linked immunosorbent assay reader (Thermo Fisher Scientific), flow cytometry (BD FACSCalibur; BD Biosciences, Flanklin Lakes, NJ, USA), western blot electrophoresis (Bio-Rad, Hercules, CA, USA), and fluorescent-PCR machine (Applied Biosystems, Foster City, CA, USA).
Cell treatment and experimental grouping
The disposable 2-L urine collection bag was used to simulate the pneumoperitoneum. A small cut was made on the lateral part of the urine collection bag through which a balanced plate was placed inside and the petri dish or a 96-well plate was attached. Then, the cut was sealed using a sealer. One port of the urine collection bag was connected to 100% CO2 gas, and the other port was connected to a pressure meter to monitor the pressure of CO2 at 12 mmHg. The temperature was set at 43 and 37°C using a cell culture incubator for 2 h. 5-FU was used at a concentration of 30 µg/ml [IC50 (5)]. The cells were grouped as follows: control group (ctrl), cells treated with only CO2 pneumoperitoneum at 37°C (group A), cells treated with hyperthermic CO2 pneumoperitoneum at 43°C (group B), cells treated with 5-FU only (group C), cells treated with CO2 pneumoperitoneum at 37°C and 5-FU (group D), and cells treated with hyperthermic CO2 pneumoperitoneum at 43°C and 5-FU (group E). The cells were placed back into the normal incubator.
In vivo tumor establishment and grouping
The in vivo tumor growth and metastasis assay was approved by the Ethics Committee of the Fifth People's Hospital of Shanghai. The SW-480 single cell suspension was injected into cecum subserosal of Balb/c nude mice to establish in situ colon cancer nude mouse model according to the experimental methods of Zheng et al (6). We used an in-house device for many mice simultaneously to warm in the CO2 pneumoperitoneum research experiment (Chinese patent no. ZL201520774334.4) (Fig. 1), we established different pneumoperitoneum intervention. The model mice were grouped as follows: control group (ctrl), CO2 pneumoperitoneum at 37°C (group A), hyperthermic CO2 pneumoperitoneum at 43°C (group B), 5-FU (group C), CO2 pneumoperitoneum at 37°C and 5-FU (group D), and hyperthermic CO2 pneumoperitoneum at 43°C and 5-FU (group E). Each group had 12 mice.
Device to simultaneously warm several mice in CO2 pneumoperitoneum research, sketch map 1. Medical CO2 cylinder 2. The disposable urline collection bags 3. Smart heater 41, 42, 43, 44 and 45. Mouse abdominal cavity A. The gas control valve B. Urine collection bags inlet switch C. Medical three-way switch D. Temperature control switch E. Medical three-way switch F. Venous indwelling needle casing inlet switch G. Venous indwelling needle casing gas switch H. Pressure gauge I. Thermometer.
Proliferation and morphology of cells
The cells were seeded onto the 6-well plate at a density of 5×105/well in 2 ml. The cells from each group were observed under the microscope and photographed at 12, 24, 36, 48, 60 and 72 h, respectively, after treatment. The experiment was repeated three times.
Cell proliferation inhibition detection by CCK-8 test
The cells (1×104/well) at logarithmic growth phase were seeded onto the 96-well plate and cultured for 24 h. The cells of each well were treated separately and continuously cultured for 12, 24, 36, 48, 60 and 72 h, respectively. CCK-8 (10 µl) was added to each well for 4 h, avoiding light. The optical density value at 450 nm was measured to determine the number of viable cells. The triplicate wells were used to calculate the average, and the cell proliferation inhibition was calculated to plot the curve of proliferation inhibition.
Cell apoptosis detection by fluorescence-activated cell sorting analysis
The cells were seeded onto the 6-well plate at a density of 5×105/well in 2 ml and cultured for 24 h. The cells of each well were treated separately and collected after another 12 h of normal culture. The cells were resuspended in 1X binding buffer after washing with ice-cold phosphate-buffered saline (PBS) twice and adjusted to the density of 1×106/ml. Cell suspensions (100 µl) were transferred to a 5-ml tube for fluorescence-activated cell sorting (FACS). Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis detection kit 5 µl each, were added into cell suspensions and incubated for 15 min at room temperature with avoiding light. The cell mixture was incubated on ice after adding 400 µl of 1X binding buffer, and FACS analysis was conducted within 1 h. FITC−/PI− was defined as normal cells, FITC+/PI− was defined as apoptotic cells at an early stage, FITC+/PI+ was defined as apoptotic cells at a late stage, and FITC−/PI+ was defined as necrotic cells. The experiment was repeated three times, and the apoptotic index (AI) and necrotic rate were calculated using the average measurements. AI = (number of apoptotic cells at a late stage + number of apoptotic cells at an early stage)/total number of cells; necrotic rate = number of necrotic cells/total number of cells.
The cells at the logarithmic growth phase were seeded onto the 24-well plate at a density of 5×104/well in 2 ml and cultured for 24 h. The normal culture was continued for 24 h after treatment of each group, and the cells were suspended in a serum-free medium after washing twice with PBS. Cells (100 µl) were seeded into the Transwell chamber at a density of 2×105/ml in triplicate format and continuously cultured for 24 h before removing the matrix gel as well as the cells in the upper chamber; the Transwell cells were counted under a microscope using Giemsa staining.
Protein expression detection by western blot analysis
The cells were continuously cultured for 12 h after treatment, and 1×107 cells were collected. The RIPA lysis buffer (150 µl) was added, and the supernatants were used for total protein determination. The protein concentration ranged between 1.5 and 2.5 mg/ml. The supernatants were aliquoted into 20 µl X2 and stored at −80°C. Sodium dodecyl sulfate (SDS) (10%) polyacrylamide separating gel and 6% concentrating gel were prepared; 80-µg proteins from each group were mixed with 5X SDS loading buffer and subjected to SDS-polyacrylamide gel electrophoresis (PAGE) after denaturing at 100°C for 10 min. The PAGE was conducted until the dye and protein markers migrated to the desired position. The proteins were then transferred onto a polyvinylidene fluoride (PVDF) membrane. The first antibody was incubated with the PVDF membrane overnight after blocking with skimmed milk solution for 1 h, and the secondary antibody was incubated for 1 h at room temperature before developing the enhanced chemiluminescence blot and photographing. The molecular weight of the targeted protein was estimated using the protein marker, and β-actin was adopted as internal control to evaluate the total amount of protein loaded onto each lane. The images were analyzed using the ImageJ software; the amount of targeted protein = relative gray scale × area (mm2). The expression level of HSP-70, caspase-3, HIF-lα and MMP-9 was calculated separately for comparison.
Fluorescence quantitative PCR
The cells were collected after each treatment, total RNA was extracted using TRIzol reagent, and cDNA was synthesized using a First Strand cDNA synthesis kit. The primers were designed and synthesized by Sangon Biotech as follows: HSP-70 forward, TACTGTGGACCTG CCAATCG and reverse, TAGCATCATTCCGCTCCTTC; HIF-1α forward, GCAGCAACGACACAGAAACT and reverse, AGCGGTGGGTAATGGAGAC; MMP-9, forward, CCAAC TACGACACCGACGAC and reverse, TGGAAGATGAATGG AAACTGG; caspase-3 forward, AGATGGTTTGAGCCTG AGCA and reverse, CAGTGCGTATGGAGAAATGG; β-actin forward, GATGCAGAAGGAGATCACTG and reverse, TAGT CCGCCTAGAAGCATTTG. The specific primers and Maxima SYBR-Green/ROX qPCR Master were mixed for quantitative PCR (qPCR), with the reaction conditions as follows: 50°C pretreated for 2 min, 95°C pre-denaturing for 10 min, 95°C denaturing for 15 sec, and 60°C annealing and extension for 60 sec for a total of 40 cycles. Triplicate wells were used, and β-actin was the internal control. Quantitation was represented by cycle threshold value (Ct value). Relative mRNA value = 2−ΔCt (ΔCt = Cttarget gene-Ctβ-actin).
In vivo tumor growth and metastasis assay
Logarithmic growth of SW-480 cells were made equal 1×107 cells/l into single cell suspension. The nude mouse abrosia for 1 day were aerosol anesthesia with B halothane, disinfected abdominal skin was cut a 0.8 cm incision in the left lower abdomen, then the cecum, sucked up 0.1 ml cell suspension with OT needle, injected into cecum subserosal, in situ colon cancer modelwas established. After 4 weeks, the model mice bearing a tumor were administered aerosol anesthesia again, and a different pneumoperitoneum intervention was established. We applied the in-house device many for many mice to simultaneously warm in the CO2 pneumoperitoneum experiment and 5-FU intraperitoneal chemotherapy, 5-FU 25 mg/kg, pneumoperitoneum duration of 1 h, at pressure of 12 mmHg. The model mice were sacrificed at 6 weeks. We observed in each group, transplantation tumor weight and viscera metastasis through celiotomy, tumor inhibitory rate = (treatment group weight-control group weight)/control group weight ×100%.
The data are presented as mean ± standard deviation (SD), and the differences between two groups were analyzed using χ2 test. The differences among groups were analyzed using one-way analysis of variance test. SPSS 13.0 software (SPSS Inc., Chicago, IL, USA) was used in the present study and P<0.05 was considered as statistically significant.
Dynamic observation of the cell proliferation and morphology under a microscope
The cells from the control group and group A, with rod-like, spindle-like, leave-like or branch-like morphology, were attached to the wall of the petri dish. All cells were in good condition with a rapid growth rate, and reached 100% confluence within 3 or 4 days, without obvious dead cells. However, the majority of cells from groups B and E started to shrink after 12 h and presented with triangular or round morphology without parapodium. The refraction of cells increased; they were detached from the wall of the petri dish and suspended into the culture medium. The cell death and cell debris could be observed after 24 h. The total cell number was reduced and normal morphology loss was aggravated with time. The dead cells and cell debris filled the whole petri dish after 48 h in group E, whereas the cell morphology was not significantly altered within 48 h in groups C and D. The shrinkage and detachment of cells from the petri dish were observed after 48 h, and necrosis and cell debris of small portion of cells were found after 72 h (Fig. 2).
Detection of cell proliferation inhibition by CCK-8 test
The cell proliferation inhibition of each group detected by CCK-8 is shown in Fig. 3. The inhibition rate was 2.05±1.80, 6.16±1.16, 4.72±4.23 and 4.96±1.01% in group A; 19.16±3.77, 25.18±2.07, 46.19±2.00 and 71.00±2.97% in group B; 14.52±2.42, 17.67±1.87, 41.60±3.87 and 49.85±6.73% in group C; 16.58±1.26, 21.69±2.03, 43.09±1.31 and 64.01±2.28% in group D; and 35.49±0.93, 41.18±1.24, 53.96±2.02 and 79.68±2.35% in group E, for 12, 24, 48 and 72 h, respectively. Compared with the control group, no obvious alteration in cell proliferation was observed in group A, whereas significant cell proliferation inhibition was observed in groups B, D, D and E (P<0.05); the strongest inhibition was observed in group E compared with groups C and D (P<0.05), indicating that hyperthermic CO2 pneumoperitoneum could reinforce the inhibitory effect of 5-FU on cell proliferation.
Cell proliferation inhibition in each treatment. Group A, CO2 pneumoperitoneum; group B, hyperthermic CO2 pneumoperitoneum; group C: 5-FU; group D, CO2 pneumoperitoneum + 5-FU; group E, hyperthermic CO2 pneumoperitoneum + 5-FU.
Detection of cell apoptosis by FACS analysis
The apoptosis of cells after treatment for 12 h was analyzed using FACS with Annexin V/PI-staining. The rate of apoptosis was calculated using the following formula: apoptosis rate (%)=R3+R5 (Fig. 4). The apoptosis rate was 11.37±0.87, 13.26±0.95, 27.45±1.14, 29.73±0.88, 36.61±0.51 and 65.20±3.11% in the control group and groups A, B, C, D and E, respectively. No significant difference in the apoptosis rate was observed between the control group and group A (P>0.05), while apoptosis significantly increased in groups B, C, D and E (P<0.05); the most significant apoptosis was observed in group E (P<0.05), indicating that hyperthermic CO2 pneumoperitoneum could enhance the apoptosis induced by 5-FU.
Effect on cell invasion
The invasion of cells was tested by Transwell assay (Fig. 5). The Transwell cell number was 243.7±14.0, 354.2±17.0, 84.5±9.7, 105.7±9.2, 126.6±8.8 and 46.2±7.13 for the control group and groups A, B, C, D and E, respectively. Compared with the control group, the Transwell cell number decreased in groups B, C, D and E, but not in group A; the decrease was most significant in group E (P<0.05), indicating that hyperthermic CO2 pneumoperitoneum and 5-FU chemotherapy both have inhibitory effect of cell invasion, hyperthermic CO2 pneumoperitoneum was able to strengthen the inhibition of cell invasion induced by 5-FU.
Detection of protein expression by western blot analysis
The western blot analysis is shown in Fig. 6 (statistical table.xlsx). Compared with the control group, the expression level of HSP-70 and caspase-3 protein remained unchanged and the expression level of HIF-1α and MMP-9 proteins increased in group A. The expression of caspase-3, HSP-70 and HIF-1α increased and the expression of MMP-9 protein decreased in groups B and E. The expression of caspase-3 increased, the expression of MMP-9 decreased, and no change in the expression of HIF-1α and HSP-70 was observed in group C. The expression of HIF-1α and caspase-3 increased, the expression of MMP-9 decreased, and no change in the expression of HSP-70 was observed in group D, indicating that the combined effect of hyperthermic CO2 pneumoperitoneum and 5-FU could promote cell apoptosis by upregulating the expression of HIF-1α, HSP-70 and caspase-3 and inhibit cell invasion by downregulating the expression of MMP-9.
Detection of mRNA level by RT-PCR
The RT-PCR result of each targeted gene 12 h after treatment is shown in Fig. 7 (statistical table.xlsx). The relative expression of HSP-70/β-actin in the control group and groups A, B, C, D and E was 5.40±0.18, 5.84±0.13, 7.51±0.19, 5.55±0.15, 5.73±0.13 and 7.95±0.15, respectively. The relative expression of MMP-9/β-actin was 10.39±0.17, 12.76±0.22, 9.16±0.15, 9.19±0.09, 9.55±0.13 and 8.07±0.08. The relative expression of HIF-1α/β-actin was 9.75±0.12, 10.70±0.13, 11.63±0.17, 9.85±0.12, 10.86±0.12 and 11.55±0.14. The relative expression of caspase-3/β-actin was 8.40±0.12, 8.28±0.14, 9.81±0.16, 9.70±0.12, 9.08±0.13 and 10.68±0.18. Compared with the control group, the expression level of HSP-70 and caspase-3 mRNA remained unchanged, while the expression level of HIF-1α and MMP-9 mRNA increased in group A (P<0.05). However, the expression level of caspase-3, HSP-70 and HIF-1α mRNA increased, while the expression level of MMP-9 decreased in groups B and E. The expression level of caspase-3 mRNA increased while that of MMP-9 mRNA decreased, and no change was observed in the expression level of HIF-1α and HSP-70 mRNA in group C. The expression level of HIF-1α and caspase-3 mRNA increased while that of MMP-9 mRNA decreased, and no change was found in the expression level of HSP-70 mRNA in group D. The present findings indicated that the combined treatment of hyperthermic CO2 pneumoperitoneum and 5-FU was able to promote cell apoptosis by upregulating the expression of HIF-1α, HSP-70 and caspase-3 and inhibited cell invasion by downregulating the expression of MMP-9.
In vivo tumor growth and metastasis
Of the 72 nude mice 55 cecum vaccination nodular lesions were seen (Fig. 8), diameter from 1.0 to 9.0 mm, the number from 1 to several. The tumorigenic success rate was 76.4% (55/72), 30 nude mice had liver, abdominal wall (Fig. 9), spleen, kidney, gastrointestinal metastases. Viscera metastasis rate was 41.7% (30/72). The number of tumorigenic success in the control group and groups A, B, C, D and E was 10, 11, 8, 9, 9 and 8. The weight of tumor was 0.76±0.05, 0.84±0.06, 0.67±0.06, 0.65±0.05, 0.74±0.05 and 0.45±0.03 g. Compared with the control group, the tumor inhibition rate of groups A, B, C, D and E was 110.5, 88.2, 85.5, 97.4 and 59.2%. Metastasis rate was 70, 72.7, 50, 44.4, 55.6 and 25%. Compared with the control group, the tumor weight and metastasis rate decreased in groups B, C, D and E, but not in group A. The most decrease was seen in group E, indicating that hyperthermic CO2 pneumoperitoneum and 5-FU chemotherapy both possess inhibition of tumor growth and metastasis, hyperthermic CO2 pneumoperitoneum was able to reinforce the inhibition induced by 5-FU.
Laparoscopy has been widely used since its adoption for the first time in colorectal surgery in 1991, and has been an important surgical option in colorectal cancer treatment. CO2 is commonly used to create pneumoperitoneum in laparoscopic surgeries. A concern exists among some surgeons that CO2 pneumoperitoneum may be associated with tumor cell migration and invasion. The potential mechanisms have been suggested to be the velocity and pressure created by CO2 pneumoperitoneum-induced tumor cell detachment and spread (6), tumor cells seeded at the puncture site of casing pipes (7), aerosol dissemination of tumor cells by ultrasonic knife, peritoneal acidic hypoxic microenvironment created by CO2 pneumoperitoneum (8), and cellular immunity alteration (9). However, other researchers believed that CO2 pneumoperitoneum had no obvious effect on tumor invasion and metastasis (10). Therefore, it was necessary to avoid any possibility of tumor invasion and metastasis caused by CO2 pneumoperitoneum. Hyperthermia is a novel therapeutic method, which increases temperature systematically or locally to treatment temperature (42–45°C) to eliminate tumor cells by altering cell signaling pathway or gene network transduction. The major mechanisms are to impair the checkpoint of cell cycle and DNA replication, alter microenvironment, and activate transcriptional factors for lysosomal enzymes, which eventually lead to tumor cell necrosis or apoptosis (11–13). In addition, CO2 gas is a carrier with good heat conduction and dispersion, which could conduct heat rapidly within the abdominal cavity. Furthermore, 5-FU is the first-line drug for colorectal carcinoma. Marked killing effect on tumor cells could be achieved by using 5-FU as intraperitoneal chemotherapy with high local concentration and prolonged action time. Intraoperative IHCP could inhibit tumor cell migration and eliminate the free tumor cells and micrometastases during operations, thus preventing or reducing tumor invasion and metastasis (14). However, most of IHCP application and studies were conducted in open surgeries; hence, information was lacking on the use of IHCP in laparoscopic operations. Peng et al discovered that hyperthermic CO2 pneumoperitoneum could inhibit colon cancer cell proliferation (15). In the present study, a simulated laparoscopic operation combined with hyperthermic CO2 pneumoperitoneum and 5-FU intraperitoneal chemotherapy was performed to observe the effect on colon cancer in vitro and in vivo.
Hyperthermic CO2 pneumoperitoneum reinforces the inhibitory effect of 5-FU on colon cancer cell proliferation. The inhibitory effect of hyperthermic CO2 pneumoperitoneum and 5-FU on colon cancer cells was observed under a microscope and using the CCK-8 test. The combination of hyperthermic CO2 pneumoperitoneum and 5-FU demonstrated the strongest inhibition. The apoptosis of colon cancer cells induced by either hyperthermic CO2 pneumoperitoneum or 5-FU, or combined treatment was observed by FACS analysis; the combined treatment had the most significant effect. It showed that hyperthermic CO2 pneumoperitoneum and 5-FU chemotherapy both inhibited tumor growth, and the combined treatment had the most significant effect in vivo. The present findings indicated that hyperthermic CO2 pneumoperitoneum could reinforce the effect of 5-FU by inhibiting cell proliferation and inducing apoptosis. HSP-70 is a molecular chaperone involved in protein synthesis, processing, folding, and transportation, and related to the occurrence, development, drug resistance, and prognosis of tumors (16). Hyperthermic CO2 pneumoperitoneum alone or combined with 5-FU was shown to upregulate the expression of HSP-70 gene and protein in the present study, which could promote tumor cell apoptosis and necrosis. Caspase-3 is a key member participating in the signaling pathways of apoptosis; it is activated in the early stage of apoptosis, to degrade the substrates in cytoplasm and nuclei, eventually leading to apoptosis (17). Caspase-3 gene and protein were both increased after hyperthermic CO2 pneumoperitoneum, or 5-FU, or their combined treatment in this study, which could initiate apoptosis and promote cell death. The expression of HIF-1α could be increased under hypoxic conditions, to sustain high energy metabolism and promote angiogenesis by regulating the expression of multiple transcriptional factors and coping with hypoxia, hence promoting tumor invasion, metastasis, and drug resistance (18). In the present study, HIF-1α gene and protein both increased after hyperthermic CO2 pneumoperitoneum, or 5-FU, or their combined treatment, and it was speculated that transcriptional factors were modulated by an increased level of HIF-1α to promote cell apoptosis and inhibit tumor invasion. The findings indicated that hyperthermic CO2 pneumoperitoneum and 5-FU combined treatment could promote cell apoptosis by upregulating the expression of HSP-70, HIF-1α and caspase-3.
Hyperthermic CO2 pneumoperitoneum reinforces the inhibitory effect of 5-FU on colon cancer cell invasion. The inhibitory effect of either hyperthermic CO2 pneumoperitoneum or 5-FU on colon cancer cell invasion was observed by Transwell assay, and the reinforced effect was achieved by the combined treatment. It showed that hyperthermic CO2 pneumoperitoneum and 5-FU chemotherapy both inhibited tumor metastasis and the combined treatment had the most significant effect in vivo. MMP-9 is a kind of zinc ion-dependent endopeptidase degrading fibrinogen type IV, the major component of extracellular matrix (ECM), leading to tumor invasion and metastasis. MMP-9 has been considered as a marker of tumor invasion and metastasis (19,20). In the present study, the expression of MMP-9 decreased by hyperthermic CO2 pneumoperitoneum, or 5-FU, or their combined treatment, leading to inhibition of ECM degradation and cancer cell invasion.
In conclusion, the hyperthermic CO2 pneumoperitoneum reinforced the inhibitory effect of 5-FU on colon cancer cell proliferation and invasion, by upregulating the expression of HSP-70, HIF-1α and caspase-3 at both mRNA and protein levels, downregulating the expression of MMP-9.
This study was supported by the finding from the Shanghai Municipal Commission of Health and Family Planning (no. 20134260), (ZHYY-ZXYJHZX-2-02).
Lin F, Pan L, Li L, Li D and Mo L: Effects of a simulated CO2 pneumoperitoneum environment on the proliferation, apoptosis, and metastasis of cervical cancer cells in vitro. Med Sci Monit. 20:2497–2503. 2014. View Article : Google Scholar : PubMed/NCBI
Kodach LL, Bos CL, Durán N, Peppelenbosch MP, Ferreira CV and Hardwick JC: Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. Carcinogenesis. 27:508–516. 2006. View Article : Google Scholar : PubMed/NCBI
Ceccarelli G, Casciola L, Nati S, Bartoli A, Spaziani A, Stefanoni M, Conti D, Fettucciari V, Di Zitti L, Valeri R, et al: Neoplastic residues in the trocar tract in oncologic laparoscopic surgery. Minerva Chir. 59:243–248. 2004.(In Italian). PubMed/NCBI
Jacobi CA, Ordemann J, Zieren HU and Müller JM: Effect of intra-abdominal pressure in laparoscopy on intraperitoneal tumor growth and development of trocar metastases. An animal experiment study in the rat model. Langenbecks Arch Chir Suppl Kongressbd. 115:(Suppl I). 529–533. 1998.[(In German)]. PubMed/NCBI
Wildbrett P, Oh A, Carter JJ, Schuster H, Bessler M, Jaboci CA and Whelan RL: Increased rates of pulmonary metastases following sham laparotomy compared to CO2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine. Surg Endosc. 16:1162–1169. 2002. View Article : Google Scholar : PubMed/NCBI
Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Haglind E, Påhlman L, Cuesta MA, Msika S, Morino M, et al: Colon Cancer Laparoscopic or Open Resection Study Group: Survival after laparoscopic surgery versus open surgery for colon cancer: Long-term outcome of a randomised clinical trial. Lancet Oncol. 10:44–52. 2009. View Article : Google Scholar : PubMed/NCBI
Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R and Riess H: The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 43:33–56. 2002. View Article : Google Scholar : PubMed/NCBI
Cai W, Dong F, Wang Z, Yang X, Zheng M and Che X: Heated and humidified CO2 pneumoperitoneum inhibits tumour cell proliferation, migration and invasion in colon cancer. Int J Hyperthermia. 30:201–209. 2014. View Article : Google Scholar : PubMed/NCBI
Tabuchi Y, Wada S, Furusawa Y, Ohtsuka K and Kondo T: Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells. Int J Mol Med. 29:380–386. 2012.PubMed/NCBI
Al-Shammaa HA, Li Y and Yonemura Y: Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol. 14:1159–1166. 2008. View Article : Google Scholar : PubMed/NCBI
Peng Y, Zheng M, Feng B, Chen X, Yu B, Lu A, Wang M, Li J, Ma J and Xu L: Hyperthermic CO2 pneumoperitoneum induces apoptosis in human colon cancer cells through Bax-associated mitochondrial pathway. Oncol Rep. 19:73–79. 2008.PubMed/NCBI
Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, Wakabayashi T, Yoshida J and Kobayashi T: Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol Immunother. 52:80–88. 2003.PubMed/NCBI
Zhu H, Feng Y, Zhang J, Zhou X, Hao B, Zhang G and Shi R: Inhibition of hypoxia inducible factor 1α expression suppresses the progression of esophageal squamous cell carcinoma. Cancer Biol Ther. 11:981–987. 2011. View Article : Google Scholar : PubMed/NCBI
Liu D, Guo H, Li Y, Xu X, Yang K and Bai Y: Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: A meta-analysis. PLoS One. 7:e312512012. View Article : Google Scholar : PubMed/NCBI
Chu D, Zhao Z, Zhou Y, Li Y, Li J, Zheng J, Zhao Q and Wang W: Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer. Ann Surg Oncol. 19:318–325. 2012. View Article : Google Scholar : PubMed/NCBI